NIH-funded research R01 grant

Investigating genetic factors affecting brain development and their link to neuropsychiatric disorders.

Official title: Cellular and developmental genetic regulation of 3' isoform diversity in the human brain and its contribution to neuropsychiatric disorders

Funded at University of Pennsylvania · NIH-10972737 · Data updated 2026-11-12

This study is looking at how differences in our genes can affect brain development during pregnancy and may play a role in conditions like autism and schizophrenia, using brain samples and stem cells to find out more about these connections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$718,662
NIH project number1R01MH137578-01
Project IDNIH-10972737 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with autism spectrum disorder or schizophrenia, particularly those who are in the developmental stages of brain growth.

Less likely to help

Patients with neuropsychiatric disorders unrelated to genetic factors or those who are not in the relevant age range may not benefit from this research.

What this research studies

This research focuses on understanding how genetic variations influence the development of the human brain, particularly during the second trimester, and how these variations may contribute to neuropsychiatric disorders like autism spectrum disorder (ASD) and schizophrenia. By integrating large-scale genomic data with functional genomic reference panels, the study aims to identify specific genetic mechanisms, such as alternative polyadenylation, that regulate gene expression in the developing brain. This approach involves analyzing brain tissues and stem-cell models to uncover dysregulation patterns associated with these disorders.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the biological mechanisms underlying neuropsychiatric disorders, potentially informing targeted therapies and interventions.

How similar studies have gone: Previous research has shown promising results in understanding genetic contributions to neuropsychiatric disorders, making this approach a continuation of established scientific inquiry.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Gandal, Michael — University of Pennsylvania
  • Study coordinator: Gandal, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.